________
SECTORS WE INVEST IN
Bootstrapped or < $10M institutional capital raised
$5+ million ARR & profitable
20%+ organic revenue growth
Or highly differentiated product
90%+ gross retention
US or Canada based
and do not call Silicon Valley home
Bootstrapped
$15+ million of revenue or $2+ million of EBITDA
20%+ organic revenue growth
Clinical models that deliver better patient outcomes at a lower cost
Patient-first approach demonstrated by high satisfaction scores
US based